Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Cancer in Inherited Bone Marrow Failure Syndromes
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
† Study has passed its completion date and status has not been verified in more than two years.